Personalized T cell therapy shows signs of clinical effectiveness against HBV-related HCC
April 12, 2018, Paris, France: Multiple adoptive transfers of T cells engineered to carry hepatitis B virus (HBV)-specific T cell ...
Month: April 2018
Punjab, India: Mass treatment of a population with chronic hepatitis C infection produces high rates of cure
12 April 2018, Paris, France: A large-scale study evaluating the feasibility of decentralized care and the provision of free direct-acting ...
Hepatitis E virus infections can be life threatening and transmitted through blood products
April 12, 2018, Paris, France: Hepatitis E virus (HEV) infection is once again in the spotlight, with two studies presented ...
Scotland: Direct-acting antiviral agent therapy reduces the burden of HCV-related decompensated cirrhosis
12 April 2018, Paris, France: Two presentations given this week at The International Liver Congress™ 2018 in Paris, France illustrate ...
Screening for hepatocellular carcinoma in patients with hepatitis C-related cirrhosis achieving sustained virological response is likely to be cost effective
12 April 2018, Paris, France: Surveillance for hepatocellular carcinoma (HCC) by ultrasound is likely to be cost effective in patients ...
Linkage to care specialist facilitates access to hepatitis C treatment for people who inject drugs
12 April 2018, Paris, France: A prospective, longitudinal study involving more than 1,000 people who inject drugs has identified a ...
A third of bacterial infections in patients with cirrhosis across the world are multi-drug resistant
12 April 2018, Paris, France: A worldwide study initiated to investigate the epidemiology and outcomes of bacterial infections in hospitalized ...
Statins associated with reduced morbidity and mortality in patients with primary sclerosing cholangitischolangi
12 April 2018, Paris, France: A large register-based study conducted in Sweden has found that statins are associated with a ...
Italy: Ongoing hepatitis A virus outbreak among men who have sex with men is linked to current outbreaks in Europe
12 April 2018, Paris, France: Hepatitis A viruses (HAVs) circulating in an ongoing outbreak among men who have sex with ...
The severity of neurocognitive impairment
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, ...
New study results from Uganda strengthen the case for contraceptive self-injection
Credit: Photo: PATH/Gabe Bienczycki. Seattle, April 12, 2018--Evidence published today on a new contraceptive option is providing one possible answer ...
Deep learning transforms smartphone microscopes into laboratory-grade devices
Credit: Ozcan Research Group/UCLA Researchers at the UCLA Samueli School of Engineering have demonstrated that deep learning, a powerful form ...
Scientists unlock path to use cell’s own nanoparticles as disease biomarkers
Credit: Louise Cooper/University of Sydney Researchers at the University of Sydney have established a method to identify individual nanoparticles released ...
St. Jude Cloud launches for researchers worldwide
Credit: Peter Barta / St. Jude Children's Research Hospital St. Jude Children's Research Hospital today launched St. Jude Cloud, an ...
The fewer the deadlier
Credit: Kyoto University / Jun-ichirou Yasunaga Japan -- A study appearing in the in Proceedings of the National Academy of ...
Cure for fission yeast genes could have bigger things ahead
Credit: OIST Scientists at the Okinawa Institute of Science and Technology Graduate University (OIST) have taken one step closer towards ...
Grad student wins design contest for health App for those considering elective mastectomy
HFES congratulates Marisa Grayson, a master's student in the Integrated Systems Engineering Department at Ohio State University, on taking first ...
Foodborne disease outbreaks
Is it possible to prepare for a food crisis? How should the severity of the health risk be estimated? When ...
First real-world studies report glecaprevir/pibrentasvir to be effective and well tolerated in chronic HCV infection
12 April 2018, Paris, France: The results of the first real-world studies assessing the effectiveness and safety of glecaprevir/pibrentasvir (G/P) ...
Novel combination therapy effective for NRAS mutant and therapy resistant melanoma
PHILADELPHIA - (April 12, 2018) - Wistar researchers have identified a novel therapeutic vulnerability in NRAS mutant melanoma and an ...
